ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis
European Respiratory Journal · 2026-07 · 68 (1) · 26E6801
DOI: 10.1183/13993003.e6801-2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 11.08.2026.
Abstract (Originalsprache)
Extract As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marlies Wijsenbeek about data from the whole follow-up period of the FIBRONEER-ILD trial of nerandomilast in progressive pulmonary fibrosis, published in this issue of the ERJ ( https://doi.org/10.1183/13993003.01899-2025 ).
Zitieren
APA
(2026). ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis. European Respiratory Journal, 68(1), 26E6801. https://doi.org/10.1183/13993003.e6801-2026
Vancouver
ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis. European Respiratory Journal. 2026;68(1):26E6801. doi:10.1183/13993003.e6801-2026
BibTeX
@article{euvimed2026,
title = {ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis},
journal = {European Respiratory Journal},
year = {2026},
volume = {68},
number = {1},
pages = {26E6801},
doi = {10.1183/13993003.e6801-2026}
}
EUVIMED